Internal Medicine, Rheumatology · Memphis, TN
NPI
1063636306
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
880 Madison Ave
Memphis, TN, 38103
Phone (901) 545-6969
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
367 services
Medicare patients, 2024
177
Average age 68
Drug cost, 2024
$9.6M
3,697 prescriptions
Company payments, 2025
$41.45
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed H Raza was code 99214 (office e&m - established), 188 times for 115 patients. In total Syed H Raza billed 367 services in 15 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 188 | 115 | $60.02 | $11K |
| 99204 Office E&M - New | Office | 32 | 32 | $88.30 | $2,826 |
| 99214 Office E&M - Established | Facility | 31 | 25 | $54.39 | $1,686 |
By year: 2022 $24K for 383 services; 2023 $20K for 319 services; 2024 $17K for 367 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed H Raza prescribed most often to Medicare patients was Enbrel Mini (Etanercept), with 336 prescriptions and refills. In total Syed H Raza wrote 3,697 Medicare prescriptions that cost $9.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Enbrel Mini Etanercept | 336 | 346 | 38 | $2.4M |
| Methotrexate Methotrexate Sodium | 306 | 548 | 63 | $6,557 |
| Humira(Cf) Pen Adalimumab | 290 | 290 | 34 | $2.0M |
| Rinvoq Upadacitinib | 195 | 205 | 25 | $1.2M |
| Prednisone Generic | 193 | 356 | 86 | $1,651 |
| Hydroxychloroquine Sulfate Generic | 158 | 417 | 53 | $8,660 |
| Gabapentin Generic | 122 | 186 | 29 | $1,117 |
| Tramadol Hcl Generic | 105 | 105 | 19 | $362 |
| Actemra Actpen Tocilizumab | 90 | 94 | 13 | $321K |
| Mycophenolate Mofetil Generic | 87 | 113 | 17 | $9,497 |
| Orencia Clickject Abatacept | 85 | 85 | Under 11 | $450K |
| Pregabalin Generic | 70 | 117 | 21 | $1,645 |
| Allopurinol Generic | 57 | 155 | 18 | $435 |
| Duloxetine Hcl Generic | 52 | 141 | 18 | $1,109 |
| Omeprazole Generic | 51 | 153 | 19 | $575 |
Brand drugs: - claims; generic drugs: 2,070 claims; opioid claims: 107.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed H Raza $41.45 ($41.45 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $41.45.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 2 | $41.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.